Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | %Female (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Tetrahedron Letters | journal | 1.260 Q1 | 181 | 1944 | 6490 | 54880 | 17409 | 6489 | 2.74 | 28.23 | 24.40 | |
2 | Tetrahedron | journal | 1.375 Q1 | 236 | 1219 | 3383 | 54820 | 9974 | 3365 | 2.88 | 44.97 | 27.23 | |
3 | Bioorganic and Medicinal Chemistry Letters | journal | 0.974 Q1 | 166 | 1063 | 2914 | 25485 | 7758 | 2910 | 2.81 | 23.97 | 30.60 | |
4 | Bioorganic and Medicinal Chemistry | journal | 0.894 Q2 | 187 | 661 | 1592 | 23374 | 4000 | 1589 | 2.46 | 35.36 | 30.99 | |
5 | Drug Discovery Today | journal | 0.823 Q2 | 215 | 320 | 1091 | 9453 | 2504 | 838 | 2.21 | 29.54 | 24.25 | |
6 | Nature Reviews Drug Discovery | journal | 7.654 Q1 | 391 | 339 | 809 | 8032 | 5111 | 255 | 5.62 | 23.69 | 15.46 | |
7 | IDrugs : the investigational drugs journal | journal | 0.187 Q4 | 39 | 206 | 616 | 1783 | 268 | 614 | 0.51 | 8.66 | 31.85 | |
8 | Current Opinion in Investigational Drugs | journal | 0.921 Q2 | 83 | 148 | 571 | 8853 | 1617 | 531 | 3.06 | 59.82 | 26.81 | |
9 | ChemMedChem | journal | 0.416 | 119 | 133 | 447 | 3338 | 619 | 446 | 1.11 | 25.10 | 43.01 | |
10 | Journal of Antibiotics | journal | 0.784 Q2 | 92 | 107 | 402 | 1781 | 601 | 344 | 1.54 | 16.64 | 24.68 | |
11 | Expert Opinion on Biological Therapy | journal | 0.943 Q1 | 102 | 140 | 378 | 11936 | 1061 | 365 | 2.90 | 85.26 | 25.28 | |
12 | Expert Opinion on Therapeutic Patents | journal | 0.550 Q3 | 88 | 120 | 374 | 6911 | 539 | 361 | 1.36 | 57.59 | 24.72 | |
13 | Pharmaceutical Biology | journal | 0.271 Q4 | 88 | 141 | 360 | 3175 | 238 | 356 | 0.53 | 22.52 | 41.11 | |
14 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.341 Q3 | 54 | 99 | 326 | 1757 | 233 | 325 | 0.73 | 17.75 | 21.39 | |
15 | Biomedical Chromatography | journal | 0.630 Q2 | 71 | 105 | 288 | 2176 | 396 | 286 | 1.31 | 20.72 | 37.90 | |
16 | Current Opinion in Molecular Therapeutics | journal | 1.121 Q1 | 67 | 82 | 268 | 4057 | 793 | 242 | 2.85 | 49.48 | 30.67 | |
17 | Current Opinion in Drug Discovery and Development | journal | 1.278 Q1 | 85 | 73 | 265 | 3560 | 1024 | 250 | 4.18 | 48.77 | 18.11 | |
18 | Expert Review of Vaccines | journal | 0.801 Q2 | 105 | 82 | 240 | 5937 | 592 | 220 | 2.60 | 72.40 | 28.76 | |
19 | Journal of Peptide Science | journal | 0.615 Q2 | 73 | 99 | 217 | 3950 | 344 | 210 | 1.71 | 39.90 | 28.83 | |
20 | Chemical Biology and Drug Design | journal | 0.780 | 91 | 128 | 214 | 4228 | 399 | 213 | 1.75 | 33.03 | 32.20 | |
21 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.691 Q2 | 92 | 79 | 212 | 2411 | 361 | 210 | 1.76 | 30.52 | 34.26 | |
22 | Phytochemical Analysis | journal | 0.567 Q3 | 83 | 73 | 180 | 1327 | 266 | 180 | 1.27 | 18.18 | 38.89 | |
23 | Expert Opinion on Therapeutic Targets | journal | 0.999 Q1 | 106 | 89 | 169 | 10586 | 417 | 159 | 2.62 | 118.94 | 28.57 | |
24 | Journal of Asian Natural Products Research | journal | 0.470 Q3 | 51 | 88 | 141 | 984 | 137 | 141 | 0.98 | 11.18 | 38.60 | |
25 | SAR and QSAR in Environmental Research | journal | 0.518 Q3 | 54 | 37 | 135 | 1114 | 237 | 135 | 1.96 | 30.11 | 28.57 | |
26 | Natural Product Reports | journal | 3.169 Q1 | 211 | 39 | 132 | 6176 | 988 | 128 | 6.70 | 158.36 | 19.72 | |
27 | Antiviral Chemistry and Chemotherapy | journal | 0.555 Q3 | 59 | 36 | 102 | 1871 | 190 | 101 | 2.01 | 51.97 | 33.33 | |
28 | International Journal of Cosmetic Science | journal | 0.199 Q4 | 77 | 32 | 99 | 886 | 80 | 99 | 0.80 | 27.69 | 28.21 | |
29 | DARU, Journal of Pharmaceutical Sciences | journal | 0.126 Q4 | 58 | 32 | 97 | 790 | 23 | 96 | 0.28 | 24.69 | 20.00 | |
30 | Drug Discovery Today: Therapeutic Strategies | journal | 0.201 Q4 | 31 | 55 | 74 | 2069 | 38 | 73 | 0.51 | 37.62 | 27.18 | |
31 | Drug Discovery Today: Disease Mechanisms | journal | 0.156 Q4 | 28 | 81 | 65 | 3216 | 19 | 64 | 0.29 | 39.70 | 30.91 | |
32 | Drug Discovery Today: Disease Models | journal | 0.130 Q4 | 33 | 48 | 64 | 1909 | 8 | 64 | 0.13 | 39.77 | 32.48 | |
33 | Drug Discovery Today: Technologies | journal | 0.335 Q3 | 62 | 55 | 62 | 1688 | 68 | 61 | 1.10 | 30.69 | 24.37 | |
34 | Human Genomics | journal | 1.921 Q1 | 68 | 22 | 43 | 868 | 117 | 42 | 2.72 | 39.45 | 32.20 | |
35 | Drug Design and Discovery | journal | 0.291 Q3 | 20 | 0 | 16 | 0 | 18 | 16 | 1.42 | 0.00 | 0.00 | |
36 | Drug Discovery World | journal | 0.192 Q4 | 14 | 38 | 10 | 417 | 6 | 9 | 0.60 | 10.97 | 18.37 | |
37 | BMC Chemical Biology | journal | 0.261 Q4 | 21 | 3 | 4 | 102 | 4 | 4 | 1.33 | 34.00 | 33.33 | |
38 | Signal | journal | 1 | 22 | 0 | 327 | 0 | 0 | 0.00 | 14.86 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®